Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v18-EN Version v17-FR
Language English French
Date Updated 2019-06-11 2019-06-10
Drug Identification Number 02231116 02231116
Brand name HYCAMTIN HYCAMTIN
Common or Proper name Hycamtin4mg/Vials 5's Hycamtin4mg/Vials 5's
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients TOPOTECAN TOPOTECAN
Strength(s) 4MG 4MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 4mg x 5 4mg x 5
ATC code L01XX L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2019-05-31 2019-05-31
Actual discontinuation date 2019-06-10 2019-06-10
Remaining supply date 2019-05-31 2019-05-31
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments